ChIP-seq from only 10,000 cells!
Since 2004, Diagenode has partnered with leading epigenetics experts and the epigenetics consortium to produce and validate epigenetic reagents including antibodies. In 2012, Diagenode revolutionized immunoprecipitation with a novel, rigorous antibody classification system for epigenetic assays. We have established a novel categorization of our antibodies into three different classes dependent on their level of validation to help you establish confidence in choosing your antibody. Finally, achieve robust results with antibodies you can TRUST.